Monday, February 26, 2018

Global Motor Gasoline Market Is Expected To Reach US$ 1,792.4 Bn By 2024 - Credence Research

The latest market report published by Credence Research, Inc. “Global Motor Gasoline Market, By Geography- Growth, Future Prospects and Competitive Analysis, 2016 - 2024” the global Motor Gasoline market was valued at US$ 1,134.1 Bn in 2016, and is expected to each US$ 1,792.4 Bn by 2024, expanding at a CAGR of 5.9% from 2016 to 2024.
Browse the full Global Motor Gasoline Market - Growth, Future Prospects and Competitive Analysis, 2016 – 2024 report at http://www.credenceresearch.com/report/motor-gasoline-market
Market Insights
Global Motor Gasoline market is projected to witness substantial growth over the forecast period. Rapid growth in disposable income of middle class especially in emerging economies of Asia Pacific is expected to fuel the demand for automobiles which in turn is projected to drive the demand for motor gasoline over the forecast period. In 2015, sales of passenger cars reached to 73.9 Mn vehicles out of which sales of passenger vehicles in China and Japan was 21.15 Mn vehicles and 4.22 Mn vehicles respectively. Followed by it, U.S. stood at second position with annual sales of 7.57 Mn vehicles annually. Robust growth in sales of passenger vehicles is projected to fuel the demand for the motor gasoline over the forecast period. However, growing use of alternatives such as LPG, Diesel and CNG as fuels coupled with increasing initiatives of government to promote use renewable fuels is anticipated to restrain the demand for global motor gasoline market during the forecast period (2016-2024).
By geography, North America was the largest region in global motor gasoline market in 2015. The growth in the region is fueled by increasing sales of automobiles in the regions especially in U.S. Followed by it, Asia Pacific is anticipated to be the second largest and fastest growing region in global motor gasoline market. China, Japan and India is anticipated to drive the demand for the motor gasoline in the region over the forecast period (2016-2024).
Considering the competition, the global motor gasoline market is expected to witness a significant rise in investment in capacity expansion for the production and supply of gasoline to cater the increasing demand for motor gasoline. Further, market has witnessed strategic mergers and collaborations among motor gasoline regional and global players. Such growth strategies are focused on increasing their market penetration in key consuming economies.
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
- No comments:
Labels: , , ,

Gastrointestinal Agents Market Is Expected To Reach US$ 21,177.7 Mn By 2025 - Credence Research

According to the latest market report published by Credence Research, Inc. “Gastrointestinal agents Market - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025,” the global gastrointestinal agents market was valued at US$ 17,255.3 Mn in 2016, and is expected to reach US$ 21,177.7 Mn by 2025, expanding at a CAGR of 2.6% from 2017 to 2025.
Browse the full report Gastrointestinal Agents Market - Growth, Future Prospects and Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/gastrointestinal-agents-market
Market Insights
Medications for gastrointestinal diseases and symptoms include prescription and nonprescription drugs, conventional and unconventional agents, simple small molecules, complex macromolecules and large recombinant proteins. These medications can be classified based upon their use:  drugs for nausea and vomiting (antiemetics), prokinetic agents, laxatives, antidiarrheal agents, drugs for acid peptic disease, drugs for irritable bowel syndrome, inflammatory bowel disease and, of course, miscellaneous. Gastrointestinal disorders include conditions such as constipation, irritable bowel syndrome, hemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps and cancer. Many of these can be prevented or minimized by maintaining a healthy lifestyle, practicing good bowel habits, and submitting to cancer screening.
The global gastrointestinal agents market is segmented by drug type as antidiarrheal, anti-ulcers, laxatives, inflammatory bowel disease drugs and irritable bowel syndrome drugs. Among these, inflammatory bowel disease held the largest share in the gastrointestinal agents market due high prevalence of inflammatory bowel disease in the region.
As of the current market scenario, North America dominates the gastrointestinal agents market. The U.S., in particular captures the largest market share in the Americas gastrointestinal agents market. However, the region is expected to witness flat growth due to maturity of this market and no anticipated competition from potential drug.  Asia Pacific is anticipated to be fastest growing market for the forecast period 2017-2015
Market Competition Assessment:
Key players in the global gastrointestinal agents market are
Abbott Laboratories, Allergan Plc. (Formerly Actavis Plc.), AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Janssen Biotech, Inc, Ranbaxy Laboratories Limited, Sanofi, Takeda Pharmaceutical, Valeant Pharmaceuticals, Inc. and others
Key Market Movements:
  • Chronic digestive disorders such as irritable bowel syndrome, inflammatory bowel disease have being commonly observed recently. Gastrointestinal (GI) diseases account for substantial morbidity, mortality, and cost. Thus rising incidence of gastrointestinal disease is key driver for market growth
  • Enormous research and development is taking place in gastrointestinal therapy in pharma industry where it has seventh largest pipeline products, surpassing other therapy areas such as dermatology, ophthalmology and respiratory. There are many drugs and biologics in pipeline especially in phase 2 and phase 3 clinical trails
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
- No comments:
Labels: , ,

Abrasives And Abrasive Machines Market To Reach US$ 38.8 Bn By 2025 - Credence Research

According to a new market research report published by Credence Research “Abrasives and Abrasive Machines Market (By Abrasive Type – Bonded, Flexible and Superabrasives: By Machine Type: Industrial and Hand-held: By End-use Industry– Automotive, Machine Tools and OEMs, Electronics and Semiconductors, Healthcare and Medical Devices and Others)  - Growth, Future Prospects, Competitive Analysis and Forecast 2017 - 2025”, the global abrasives and abrasive machines market stood at US$ 23.1 Bn in 2016 and is estimated to expand with a CAGR of 6.0% from 2017 to 2025.
Market Insights
Industrial manufacturing and processing includes an extensively wide array of processes requiring cutting and grinding operations. Due to rapidly growing competition across the sector, it has become necessary to ensure fast and precise processes so as to maintain optimum quality of the end-products. Thus, it becomes essential for the manufacturers to adopt viable solutions for specific operations in order to facilitate the required output. Numerous abrasive cutting and grinding processes require variety of abrasive products that may differ in shape, size and composition. This has been one of the most prominent factors responsible for the overall abrasives market growth. Over the period of time, abrasives have replaced traditional cutting processes leading to development of wide range of abrasive products. However, the major challenge for the market players is to select the composition of abrasive materials.
Market players are keen on providing abrasive solutions catering to the varied needs of industrial manufacturing and processing industry. Majority of the companies operating in the industry produce abrasive products designed to be applied to specific models of the machines/workpieces. This has gradually led to emergence of a variety of abrasive minerals, glues, backings, resins, matrix materials in different shapes and sizes, thereby leading to sustainable market growth.
Competitive Insights:
One of the major trend observed in the market is the acquisition of other abrasive material manufacturers. This has been one of the most prevalent strategies adopted by the market players so as to ensure their competitive edge over other companies in the market. Leading companies such as Saint-Gobain SA and the 3M Company have a long history of acquisitions that has helped them gain a promising position in the overall market. Companies typically acquisition for expanding their product portfolio across different segments (such as superabrasives) and geographical reach. Due to increasing fragmentation in the market, the trend of inorganic expansion is projected to prevail throughout the forecast period.
Key Trends:
  • Increasing adoption of superabrasives in order to achieve enhanced finishing and refined end-products
  • Rising demand for hand-held polishing machines leading to higher demand for abrasives in the do-it-yourself (DIY) sector
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
- No comments:
Labels: , ,

Global Mannequin-Based Simulation Market Is Expected to Reach Worth USD 1,791.4 Mn by 2022 - Credence Research


According to the latest report published by Credence Research, Inc. “Mannequin-Based Simulation Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the  mannequin-based simulation market was valued at USD 521.6 Mn in 2015, and is expected to reach USD 1,791.4 Mn by 2022, expanding at a CAGR of 25.1% from 2016 to 2022.

Browse the full report Mannequin-Based Simulation: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/mannequin-based-simulation-market
Market Insights                                                  
Mannequin-based simulators have become a common article in several fields such as ICUs, operating room, delivery rooms, emergency department, research and academics, military training and others. These simulators can be used across all levels of learning and experienced personnel from multidisciplinary areas. Simulated training provides healthcare and medical professionals with extensive practice opportunity in interactive settings without risking patient’s life.
Growing population of simulation-based training modules across all verticals is the major driver of this market. On the other hand, paucity of required funds may hold the growth of this market, particularly in the less developed regions. Among the various simulation types available, the patient simulators segment currently is the market leader in terms of market revenue. It will also exhibit a moderate growth rate corresponding to that of the overall mannequin-based simulation market. Ethical sensitivity about patients being made subjects and related patient safety risks, shifts taking place in medical training and treatment development are among the most significant drivers of this market.  
North America and Europe are the largest regional markets for mannequin-based simulation solutions. Asia-Pacific is observed to be the fastest growing region during the forecast period. The growth of this region is attributed to the development of healthcare infrastructure, evolution of regulation bodies, rising preference for minimally invasive treatment procedures and growing demand for high quality healthcare that demands advanced training to healthcare staff and personnel.  
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
- No comments:
Labels: , , ,

Listeria Monocytogenes Infections Treatment Market is Expected to Reach USD 5,056.3 Mn by 2022 - Credence Research

The latest market report published by Credence Research, Inc. “Global Listeria monocytogenes Infections Treatment Market - Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 - 2022,” the Listeria monocytogenes infections treatment market was valued at USD 3,624.9 Mn in 2015, and is expected to reach USD 5,056.3 Mn by 2022, expanding at a CAGR of 4.74% from 2016 to 2022.
Browse the full report Listeria monocytogenes Infections Treatment Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at http://www.credenceresearch.com/report/listeria-monocytogenes-infections-treatment-market
Market Insights
Listeria monocytogenes, is an important pathogen in pregnant patients, neonates, elderly individuals, and immunocompromised individuals, although an uncommon cause of illness in the general population. Listeria monocytogenes is a bacterial pathogen capable of causing severe infections in humans, often with fatal outcomes. According to USFDA, published studies suggest that 1- 8% of humans may be intestinal carriers of Listeria. According to Unites States Department of Agriculture (USDA), Listeria causes about 280 cases of illness in newborns in a typical year, resulting in 60 deaths and stillbirths. Infants can be infected before birth, and this infection can cause serious disability in newborns. About 35 infants are disabled as a result of infection from Listeria each year. The key factors assisting the growth of Listeria monocytogenes infections treatment market are rise in prevalence of foodborne diseases, stringent laws and policies issued by FDA, rising demand for healthy and microbial-free food, and high public awareness related to foodborne diseases in developed countries.
Pipeline Analysis
The phase III drugs included in the pipeline analysis are Carbavance (The Medicines Company), Telavancin (Theravance Biopharma Antibiotics, Inc.), Daptomycin (Merck & Co.), Prulifloxacin (Merck & Co.), and DTaP-IPV/Hib combined vaccine (Sanofi S.A.). According to market experts, the diversity of the several molecule types in the biologic group shows a certain level of innovation, with newer avenues being explored in accounts of recent failures. Overall, late stage clinical trials have highlighted very few molecules that could potentially replace current treatments during the forecast period.
Key Market Movements
  • Rising prevalence of foodborne infections in developed and developing countries
  • The incidence and prevalence of Listeria monocytogenes infections is high in pediatric and geriatric population
  • Stringent regulatory policies applied by FDA and other government agencies across the world is expected to reduce the risk of infection outbreak
  • Novel and developed treatments in pipeline are expected to assist the overall market growth of Listeria monocytogenes infections treatment market
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
- No comments:
Labels: ,

Opioid Induced Constipation Drugs Market is expected to reach USD 2,779.24 Mn by 2022 - Credence Research

The latest market report published by Credence Research “Global Opioid Induced Constipation Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the opioid induced constipation drugs market was valued at USD 1,933.2 Mn in 2015, and is expected to reach USD 2,779.24 Mn by 2022, expanding at a CAGR of 4.6% from 2016 to 2022; where North America is has the largest market share.
Browse the full report Opioid Induced Constipation Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016–2022 at http://www.credenceresearch.com/report/opioid-induced-constipation-oic-drugs-market
Market Insights
Opioids affect the gastrointestinal tract by increasing the required time for moving stool from the gastric system. Opioids also partially paralyze the digestive system thus leaving food remains in the GI tract for a longer time period. They also reduce digestive secretions and the urge to defecate. According to this report, North America is the largest OIC drugs market and is valued at USD 794.5 Mn in 2015.
North America has two of the most developed nations in the world with advanced and well organized healthcare infrastructures: U.S. and Canada. The overall drugs market is the largest in the U.S. The OIC drugs market in the North America is expected to maintain a steady growth and exhibit further potential with the commercialization of current pipeline drugs. Moreover, greater potential due to government initiatives to further improve healthcare services in the society by providing latest technical and pharmacological treatments support the domination of North America market. Growing lifestyle related diseases, increased healthcare spending mad technological advancement in pain management are the other prime factors responsible for the growth of this market.
Europe on the other hand, exhibits mixed markets for healthcare sector. The region constantly adopts the latest healthcare systems to provide the best possible healthcare assistance for patients. The healthcare spending of European countries is increasing considerably. According to W.H.O. estimations, in 2013, the EU spent USD 3,520 per person in healthcare. Constipation is very common in Europe and the region has the largest share in drug market for OIC treatment.
On the other hand, Asia Pacific is the fastest growing regional market for OIC drugs. Rapid evolution of healthcare infrastructure across the region, coupled with the rising incidence of OIC is the major responsible factors for the growth of OIC drugs in the region. China has the largest market share for the drugs manufacturers in this region as this is one of the most potential markets for pharmaceutical giants. The Drugs used for treatment of these disorders in APAC regions are the global brands and pharmaceutical companies who are ruling the constipation drug market. Some of the common drugs are AMITIZA, LINZEES and various others like Ironwood also has partnered linaclotide with Astellas Pharma Inc. for development and commercialization in Japan and certain other Asian countries and with AstraZeneca for development and commercialization in China.
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
- No comments:
Labels: , ,

Medical Adhesives and Sealants Market to Reach Worth USD 2,073.7 Mn by 2022 - Credence Research

According to the latest report published by Credence Research, Inc. “Medical Adhesives and Sealants Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the medical adhesives and sealants market was valued at USD 6,952.6 Mn in 2015, and is expected to reach USD 12,073.7 Mn by 2022, expanding at a CAGR of 8.1% from 2016 to 2022.
Browse the full report Medical Adhesives and Sealants Market - Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/medical-adhesives-and-sealants-market
Market Insights            
Medical adhesives and sealants are chemical products used for binding components involved in medical procedures. Key driver of this market is growth in the number of dental procedures worldwide. Excellent bonding characteristics of medical adhesives has urged their demand in dental and orthopedic procedures. On the other hand, stringent regulatory compliance terms may hold the otherwise rapid growth of this market.
These products are available in synthetic and natural product variants, each of the both having further different product types. Among the sub-types of synthetic adhesives and sealants, a majority of market share is taken by acrylic adhesives and sealants. Segments such as polyethylene glycol will progress at the fastest growth rate during the forecast period. Product evolution and better bonding features in the products will define the overall market growth of these segments.
Based on applications such as dental, internal and external uses, the internal applications segment is estimated to be the largest segment with almost half of the market revenue coming from the same. This segment will also demonstrate an above average growth rate during the forecast period. Among the end-users, dental care segment will progress at the fastest growth rate through 2022. Phenomenal growth of the dental procedures market is the prime contributor for the corresponding progress of this segment.
Based in geographical distribution, North America is the clear leader in the global medical adhesives and sealants market. The region is the largest consumer of adhesives and sealant products attributed by the usual high demand for technologically advanced products coupled with higher awareness between both patients and care-givers. Asia-Pacific and Latin America markets will undergo the fastest growth during the forecast period due to large scale medical tourism and rapid development of healthcare infrastructure in the regions.
This market is highly competitive and fragmented, with several consolidation activities being undertaken at present. Some of the notable players in the global medical adhesives and sealants market are 3M Company, Johnson & Johnson, Adhesive Research, Inc. Dentsply Limited and others.
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
- No comments:
Labels: , , ,
Subscribe to: Posts (Atom)

Cancer Biomarkers Market is Expected to Reach USD 30,284.5 Mn by 2025: Credence Research

The latest market report published by Credence Research, Inc. “Global  Cancer Biomarkers Market  - Growth, Share, Opportunities, Competiti...